These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18831063)

  • 1. All in the family: disclosure of "unwanted" information to an adolescent to benefit a relative.
    Denny CC; Wilfond BS; Peters JA; Giri N; Alter BP
    Am J Med Genet A; 2008 Nov; 146A(21):2719-24. PubMed ID: 18831063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical and policy lessons to be learned from a family with inherited bone marrow failure.
    Ross LF
    Am J Med Genet A; 2008 Nov; 146A(21):2715-8. PubMed ID: 18924227
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.
    Ghavamzadeh A; Alimoghadam K; Nasseri P; Jahani M; Khodabandeh A; Ghahremani G
    Bone Marrow Transplant; 1999 Feb; 23(3):299-301. PubMed ID: 10084264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita.
    Al-Rahawan MM; Giri N; Alter BP
    Int J Hematol; 2006 Apr; 83(3):275-6. PubMed ID: 16720563
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyskeratosis congenita.
    Savage SA; Alter BP
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):215-31. PubMed ID: 19327580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length in inherited bone marrow failure syndromes.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes.
    Arias-Salgado EG; Galvez E; Planas-Cerezales L; Pintado-Berninches L; Vallespin E; Martinez P; Carrillo J; Iarriccio L; Ruiz-Llobet A; Catalá A; Badell-Serra I; Gonzalez-Granado LI; Martín-Nalda A; Martínez-Gallo M; Galera-Miñarro A; Rodríguez-Vigil C; Bastos-Oreiro M; Perez de Nanclares G; Leiro-Fernández V; Uria ML; Diaz-Heredia C; Valenzuela C; Martín S; López-Muñiz B; Lapunzina P; Sevilla J; Molina-Molina M; Perona R; Sastre L
    Orphanet J Rare Dis; 2019 Apr; 14(1):82. PubMed ID: 30995915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita: report of a case.
    Comoli P; Basso S; Huanga GC
    Int J Hematol; 2005 Jul; 82(1):35-7. PubMed ID: 16105756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.
    Li F; Li W; Qiao X; Xie X
    Int J Hematol; 2019 Mar; 109(3):328-335. PubMed ID: 30604317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between donor leukocyte telomere length and survival after unrelated allogeneic hematopoietic cell transplantation for severe aplastic anemia.
    Gadalla SM; Wang T; Haagenson M; Spellman SR; Lee SJ; Williams KM; Wong JY; De Vivo I; Savage SA
    JAMA; 2015 Feb; 313(6):594-602. PubMed ID: 25668263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A parent's point of view on the American Academy of Pediatrics policy statement: Children as hematopoietic stem cell donors.
    Revera GH; Frangoul H
    Pediatr Blood Cancer; 2011 Apr; 56(4):515-6. PubMed ID: 21298733
    [No Abstract]   [Full Text] [Related]  

  • 12. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
    Alter BP; Rosenberg PS; Giri N; Baerlocher GM; Lansdorp PM; Savage SA
    Haematologica; 2012 Mar; 97(3):353-9. PubMed ID: 22058220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal Hemorrhagic Gastrointestinal Angioectasia after Bone Marrow Transplantation for Dyskeratosis Congenita.
    Imai J; Suzuki T; Yoshikawa M; Dekiden M; Nakae H; Nakahara F; Tsuda S; Mizukami H; Koike J; Igarashi M; Yabe H; Mine T
    Intern Med; 2016; 55(23):3441-3444. PubMed ID: 27904106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.
    Fogarty PF; Yamaguchi H; Wiestner A; Baerlocher GM; Sloand E; Zeng WS; Read EJ; Lansdorp PM; Young NS
    Lancet; 2003 Nov; 362(9396):1628-30. PubMed ID: 14630445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmet needs of siblings of pediatric stem cell transplant recipients.
    Pentz RD; Alderfer MA; Pelletier W; Stegenga K; Haight AE; Hendershot KA; Dixon M; Fairclough D; Hinds P
    Pediatrics; 2014 May; 133(5):e1156-62. PubMed ID: 24777206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited aplastic anaemia.
    Dokal I
    Hematol J; 2003; 4(1):3-9. PubMed ID: 12692514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia.
    Barade A; Aboobacker F; Korula A; Lakshmi K; Devasia A; Abraham A; Mathews V; Edison E; George B
    Br J Haematol; 2022 Feb; 196(3):724-734. PubMed ID: 34605011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.